Semaglutide, the active ingredient in the injectable diabetes drug Ozempic and its weight-loss sister prescription Wegovy, seems to have yet another unfortunate side effect: putting back on the weight, and then some, when one stops taking it. As two women told The Messenger in interviews about their experiences with the injectable drugs, the weight gain wasn't […]